×
About 4,770 results

ALLMedicine™ Salpingo-oophorectomy Center

Research & Reviews  2,263 results

Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women Wit...
https://doi.org/10.1001/jamaoncol.2020.7995
JAMA Oncology; Choi YH, Terry MB et. al.

Feb 25th, 2021 - Women with pathogenic variants in BRCA1 and BRCA2 are at high risk of developing breast and ovarian cancers. They usually undergo intensive cancer surveillance and may also consider surgical interventions, such as risk-reducing mastectomy or risk-...

Performance Assessment for Laparoscopic Total Hysterectomy in the Operating Room: Valid...
https://doi.org/10.1016/j.jmig.2021.02.013
Journal of Minimally Invasive Gynecology; Crochet P, Netter A et. al.

Feb 23rd, 2021 - The technical conduct of total laparoscopic hysterectomy (LH) is critical to surgical outcomes. This study explored the validity evidence of an objective scale specific to the assessment of technical skills (H-OSATS) for seven tasks of the LH with...

The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-...
https://doi.org/10.1007/s10689-021-00232-6 10.6004/jnccn.2017.0003 10.1186/s12905-014-0150-5 10.1001/jama.2017.21421 10.1038/s10038-017-0355-1 10.1016/j.ygyno.2016.07.104 10.1016/j.pec.2014.07.004 10.1007/s10897-016-9949-6 10.1007/s10689-012-9596-5 10.1016/j.zefq.2017.05.019 10.1186/1472-6963-13-408 10.1037/hea0000229 10.1007/s10897-009-9245-9 10.1016/S0738-3991(98)00026-3 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G 10.1016/j.pec.2012.03.002 10.1186/bcr2118 10.1371/journal.pone.0203469 10.1159/000441714 10.1191/1478088706qp063oa 10.1080/2159676X.2019.1628806 10.1177/1525822X05279903 10.1016/j.pec.2017.03.013 10.1007/s10897-013-9667-2 10.1097/NCC.0b013e3182642cb5 10.1186/1472-6874-10-24 10.1080/07347332.2017.1292574 10.1007/s10897-015-9877-x 10.1007/s10897-015-9878-9 10.1038/s41416-019-0446-1 10.1007/s10689-011-9420-7 10.1001/jama.2017.7112 10.1200/JCO.2013.53.2820 10.1177/0272989X08327066 10.1080/07347330802359776 10.1080/10410236.2016.1250187 10.1177/109019819802500603 10.1016/j.vaccine.2017.04.010 10.1371/journal.pone.0080051 10.30476/MEJC.2019.78702.0 10.1007/s00520-015-2611-2 10.1002/pon.4902 10.1177/1534735417745248 10.7314/apjcp.2012.13.8.3723 10.7314/apjcp.2015.16.1.145 10.1177/0272989x17715628 10.1186/s12910-017-0241-6 10.1080/10410236.2016.1214224 10.4278/ajhp.120113-QUAN-15 10.18632/oncotarget.24382 10.1002/14651858.CD001431.pub5
Familial Cancer; Sa'at H, Lee YK et. al.

Feb 19th, 2021 - The decision to have risk-reducing salpingo-oophorectomy (RRSO) by BRCA mutation carriers to reduce the risk of ovarian cancer is difficult. The choice involves trade-offs in terms of its risks and benefits. To date, understanding the decision-mak...

What happens after menopause? (WHAM): A prospective controlled study of depression and ...
https://doi.org/10.1016/j.ygyno.2021.02.001
Gynecologic Oncology; Hickey M, Moss KM et. al.

Feb 15th, 2021 - Risk-reducing bilateral salpingo-oophorectomy (RRBSO) substantially reduces ovarian cancer risk in women with pathogenic gene variants and is generally recommended by age 34-45 years. Natural menopause is a vulnerable period for mood disturbance, ...

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early...
https://doi.org/10.1136/jmedgenet-2020-107501
Journal of Medical Genetics; Gaba F, Goyal S et. al.

Feb 11th, 2021 - Acceptance of the role of the fallopian tube in 'ovarian' carcinogenesis and the detrimental sequelae of surgical menopause in premenopausal women following risk-reducing salpingo-oophorectomy (RRSO) has resulted in risk-reducing early-salpingecto...

see more →

Guidelines  3 results

Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial
https://annals.org/aim/article-abstract/2749725/menopausal-estrogen-alone-therapy-health-outcomes-women-without-bilateral-oophorectomy
Annals of Internal Medicine;

Sep 9th, 2019 - Background: Whether health outcomes of menopausal estrogen therapy differ between women with and without bilateral salpingo-oophorectomy (BSO) is unknown. Objective: To examine estrogen therapy outcomes by BSO status, with additional stratificati...

Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Opportunistic-Salpingectomy-as-a-Strategy-for-Epithelial-Ovarian-Cancer-Prevention

Mar 25th, 2019 - Opportunistic salpingectomy may offer obstetrician–gynecologists and other health care providers the opportunity to decrease the risk of ovarian cancer in their patients who are already undergoing pelvic surgery for benign disease. By performing s.

ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.
https://doi.org/10.1097/01.AOG.0000291580.39618.cb
Obstetrics and Gynecology;

Dec 31st, 2007 - ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.|2008| ,|standards,surgery,methods,genetics,prevention & control,standards,

see more →

Clinicaltrials.gov  2,345 results

Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women Wit...
https://doi.org/10.1001/jamaoncol.2020.7995
JAMA Oncology; Choi YH, Terry MB et. al.

Feb 25th, 2021 - Women with pathogenic variants in BRCA1 and BRCA2 are at high risk of developing breast and ovarian cancers. They usually undergo intensive cancer surveillance and may also consider surgical interventions, such as risk-reducing mastectomy or risk-...

Performance Assessment for Laparoscopic Total Hysterectomy in the Operating Room: Valid...
https://doi.org/10.1016/j.jmig.2021.02.013
Journal of Minimally Invasive Gynecology; Crochet P, Netter A et. al.

Feb 23rd, 2021 - The technical conduct of total laparoscopic hysterectomy (LH) is critical to surgical outcomes. This study explored the validity evidence of an objective scale specific to the assessment of technical skills (H-OSATS) for seven tasks of the LH with...

The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-...
https://doi.org/10.1007/s10689-021-00232-6 10.6004/jnccn.2017.0003 10.1186/s12905-014-0150-5 10.1001/jama.2017.21421 10.1038/s10038-017-0355-1 10.1016/j.ygyno.2016.07.104 10.1016/j.pec.2014.07.004 10.1007/s10897-016-9949-6 10.1007/s10689-012-9596-5 10.1016/j.zefq.2017.05.019 10.1186/1472-6963-13-408 10.1037/hea0000229 10.1007/s10897-009-9245-9 10.1016/S0738-3991(98)00026-3 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G 10.1016/j.pec.2012.03.002 10.1186/bcr2118 10.1371/journal.pone.0203469 10.1159/000441714 10.1191/1478088706qp063oa 10.1080/2159676X.2019.1628806 10.1177/1525822X05279903 10.1016/j.pec.2017.03.013 10.1007/s10897-013-9667-2 10.1097/NCC.0b013e3182642cb5 10.1186/1472-6874-10-24 10.1080/07347332.2017.1292574 10.1007/s10897-015-9877-x 10.1007/s10897-015-9878-9 10.1038/s41416-019-0446-1 10.1007/s10689-011-9420-7 10.1001/jama.2017.7112 10.1200/JCO.2013.53.2820 10.1177/0272989X08327066 10.1080/07347330802359776 10.1080/10410236.2016.1250187 10.1177/109019819802500603 10.1016/j.vaccine.2017.04.010 10.1371/journal.pone.0080051 10.30476/MEJC.2019.78702.0 10.1007/s00520-015-2611-2 10.1002/pon.4902 10.1177/1534735417745248 10.7314/apjcp.2012.13.8.3723 10.7314/apjcp.2015.16.1.145 10.1177/0272989x17715628 10.1186/s12910-017-0241-6 10.1080/10410236.2016.1214224 10.4278/ajhp.120113-QUAN-15 10.18632/oncotarget.24382 10.1002/14651858.CD001431.pub5
Familial Cancer; Sa'at H, Lee YK et. al.

Feb 19th, 2021 - The decision to have risk-reducing salpingo-oophorectomy (RRSO) by BRCA mutation carriers to reduce the risk of ovarian cancer is difficult. The choice involves trade-offs in terms of its risks and benefits. To date, understanding the decision-mak...

What happens after menopause? (WHAM): A prospective controlled study of depression and ...
https://doi.org/10.1016/j.ygyno.2021.02.001
Gynecologic Oncology; Hickey M, Moss KM et. al.

Feb 15th, 2021 - Risk-reducing bilateral salpingo-oophorectomy (RRBSO) substantially reduces ovarian cancer risk in women with pathogenic gene variants and is generally recommended by age 34-45 years. Natural menopause is a vulnerable period for mood disturbance, ...

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early...
https://doi.org/10.1136/jmedgenet-2020-107501
Journal of Medical Genetics; Gaba F, Goyal S et. al.

Feb 11th, 2021 - Acceptance of the role of the fallopian tube in 'ovarian' carcinogenesis and the detrimental sequelae of surgical menopause in premenopausal women following risk-reducing salpingo-oophorectomy (RRSO) has resulted in risk-reducing early-salpingecto...

see more →

News  159 results

Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest
https://www.staging.medscape.com/viewarticle/939275

Oct 15th, 2020 - "Many physicians would assume that prevention of cancer, especially cancer as serious as ovarian cancer, trumps all other decision making, but when we really listen to high-risk women, they want to have options," Karen Lu, MD, chair of gynecologic...

Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest
https://www.medscape.com/viewarticle/939275

Oct 15th, 2020 - "Many physicians would assume that prevention of cancer, especially cancer as serious as ovarian cancer, trumps all other decision making, but when we really listen to high-risk women, they want to have options," Karen Lu, MD, chair of gynecologic...

Family history of MI may increase CVD mortality after bilateral salpingo-oophorectomy
https://www.mdedge.com/obgyn/article/218475/menopause/family-history-mi-may-increase-cvd-mortality-after-bilateral-salpingo?channel=27970
Christopher Palmer

Mar 5th, 2020 - Family history of premature MI (FHPMI) in women with bilateral salpingo-oophorectomy (BSO) modifies the increased mortality associated with heart disease and cardiovascular disease in those women, according to an analysis published in Menopause. D.

Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial
https://annals.org/aim/article-abstract/2749725/menopausal-estrogen-alone-therapy-health-outcomes-women-without-bilateral-oophorectomy
Annals of Internal Medicine;

Sep 9th, 2019 - Background: Whether health outcomes of menopausal estrogen therapy differ between women with and without bilateral salpingo-oophorectomy (BSO) is unknown. Objective: To examine estrogen therapy outcomes by BSO status, with additional stratificati...

The ovarian remnant syndrome
https://www.mdedge.com/surgery/article/205271/surgery/ovarian-remnant-syndrome?channel=352
Charles E. Miller, MD

Jul 24th, 2019 - A 45-year old woman was referred by her physician to my clinic for continued pain after total hysterectomy and bilateral salpingo-oophorectomy. The patient initially had undergone a robot-assisted total laparoscopic hysterectomy, bilateral salping.

see more →